← Back to Patent Explorer
US4452818A Expired / Lapsed US ⏱️ 0.0 years remaining

Extraocular method of treating the eye with liquid perfluorocarbons

Assignee: Individual
•
Filing: 1982-03-19
•
Granted: 1984-06-05
•
Expires: 2002-03-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Extraocular ophthalmic preparations useful as therapeutic, lubricating or protective agents are disclosed. Liquid perfluorocarbons and substituted derivatives are the active components of the ophthalmic preparations. The neat perfluorocarbon liquids are not aqueous, wherefore, isotonicity and pH need not be considered in their preparation. Liquid sterility may be maintained without the addition of preservatives. Cornea and conjunctiva surfaces are provided with greater amounts of oxygen when the perfluorocarbon liquids are employed as eye drops.

Inventors

  • 👤 Sterling J. Haidt

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 09:02
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/02; A61K31/025; A61K9/00; A61K9/0012; A61K9/0048; A61P; A61P27/00; A61P27/02

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 57 words
A method for treating the eyes and providing lubrication and protection to the surface of the eye which comprises topically applying to the eye a composition comprising as an essential ingredient a transparent or light transmissive, stable, inert, viscous perfluorocarbon or substituted derivative thereof having oxygen carrying properties in an amount sufficient to act as a lubricant.
Claim 2
Independent Claim 57 words
A method for treating the eyes and providing lubrication and protection to the surface of the eye which comprises topically applying to the eye a composition comprising as an essential ingredient a transparent or light transmissive, stable, inert, viscous perfluorocarbon or substituted derivative thereof having oxygen carrying properties in an amount sufficient to act as a lubricant.
Claim 3
Dependent Claim 11 words
The method of claim 1 wherein said liquid is a perfluorocyclocarbon.
Claim 4
Dependent Claim 29 words
The method of claim 2 wherein said perfluorocyclocarbon is selected from the group consisting of perfluoro(mthylcyclohexane), perfluoro(1,3-dimethylcyclohexane), perfluoro(decahydronaphthalene), perfluoro(decahydro-1-methylnaphthalene), perfluoro(decahydrodimethylnaphthalene), perfluorodimethyladamantane, perfluorotrimethylbicyclo[3.3.1.]nonane, perfluorotetrahydrodicyclopentadiene, perfluorobicyclo[5.3.0.]decane and perfluorodimethylbicyclo[3.3.1.]nonane, or mixtures thereof.
Claim 5
Dependent Claim 10 words
The method of claim 1 wherein said perfluorocarbon is perfluoro-1-methyldecalin.
Claim 6
Dependent Claim 12 words
A method of claim 1 wherein said eye contains a contact lens.
Claim 7
Dependent Claim 22 words
A therapeutic method as defined in claim 1 wherein said composition is applied topically by instilling said composition into an eye cul-de-sac.
Claim 8
Dependent Claim 22 words
A therapeutic method as defined in claim 1 wherein said composition is dispersed across the corneal and conjunctiva surfaces of the eye.
Claim 9
Dependent Claim 22 words
A therapeutic method as defined in claim 1 wherein said composition also contains a pharmaceutical agent present in a therapeutically effective amount.
Claim 10
Dependent Claim 35 words
A therapeutic method as defined in claim 1 wherein said composition is in a form selected from the group consisting of a neat liquid, an emulsion, an ointment, a gel, a solution, and a suspension.
Claim 11
Dependent Claim 27 words
A therapeutic method as defined in claim 5 wherein said composition is dispersed to the corneal epithelium prior to inserting the contact lens onto the corneal epithelium.
Claim 12
Dependent Claim 31 words
A therapeutic method as defined in claim 5 wherein said composition has been applied to the contact lens after or before the contact lens has been inserted onto the corneal epithelium.

References Cited (Backward Citations)

US3911138A Cited
US3911138B1 Cited
US4141973A Cited
US4141973B1 Cited
US4105798A Cited
US4110474A Cited
US4187252A Cited
US4366169A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-06-05 1987-12-05 1988-06-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-06-05 1991-12-05 1992-06-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-06-05 1995-12-05 1996-06-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag